Cyril Charron

机构：Inserm, Université de Versailles Saint-Quentin-en-Yvelines, CHU Ambroise Paré, Assistance Publique – Hôpitaux de Paris, Centre de recherche en Epidémiologie et Santé des Populations, Hôpital Ambroise-Paré · ORCID：0000-0002-7328-525X

发表论文 173 篇 · 总被引 6457 次 · h-index 44

代表论文

• Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19 (2022 · JAMA · 被引 155)
• Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial (2022 · JAMA · 被引 140)
• Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study) (2022 · Intensive Care Medicine · 被引 112)
• Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial (2021 · Intensive Care Medicine · 被引 101)
• Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals (2021 · Critical Care · 被引 82)
• Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study (2022 · The Lancet Regional Health - Europe · 被引 71)